Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Embecta Corp. - Common Stock (NQ:EMBC)

3.110 +0.020 (+0.65%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Embecta Corp. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
EMBECTA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Embecta Corp. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Rosen Law Firm Urges Embecta Corp. (NASDAQ: EMBC) Stockholders to Contact the Firm for Information About Their Rights
From Rosen Law Firm
Via Business Wire
News headline image
Securities Fraud Investigation Into Embecta Corp. (EMBC) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Embecta Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – EMBC
From The DJS Law Group
Via Business Wire
Embecta Corp. (NASDAQ:EMBC) Plunges Over 25% on Q2 Fiscal 2026 Miss ↗
Via Chartmill
Embecta Corp (NASDAQ:EMBC) Stock Falls 6.5% on Q1 Revenue Miss Despite EPS Beat ↗
Via Chartmill
News headline image
EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
Investor Notice: Robbins LLP Informs Investors of the Embecta Corp. Class Action Lawsuit
From Robbins LLP
Via Business Wire
News headline image
EMBC Investors Have Opportunity to Join Embecta Corp. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
An Overview of Embecta's Earnings ↗
 
Via Benzinga
News headline image
EMBC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Embecta Corp.
From Kirby McInerney LLP
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. is Investigating Embecta Corp. on Behalf of Embecta Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
EMBC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Embecta Corp.
From Kirby McInerney LLP
Via GlobeNewswire
News headline image
EMBC SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
From Kirby McInerney LLP
Via Business Wire
News headline image
Embecta Faces U.S. Reset as CEO Bets on GLP-1, Owen Mumford Diversification ↗
Embecta (NASDAQ:EMBC) President and CEO Devdatt Kurdikar said the company’s recent U.S. business reset reflected a combination of customer-specific share loss, softer market trends and... 
Via MarketBeat
News headline image
Why Embecta Stock Plummeted Today ↗
Embecta's most recent quarterly report didn't give investors much to be exicited about. 
Via The Motley Fool
News headline image
Embecta (EMBC) Q2 2026 Earnings Transcript ↗
Embecta (EMBC) Q2 2026 Earnings Transcript 
Via The Motley Fool
Keep an eye on the top gainers and losers in Tuesday's session. ↗
Via Chartmill
Which stocks are gapping on Tuesday? ↗
Via Chartmill
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
News headline image
The “New BD”: A Deep-Dive Research Report on Becton, Dickinson and Company (BDX) in 2026
As of April 3, 2026, the medical technology landscape is undergoing a radical transformation, and few companies embody this evolution more than Becton, Dickinson and Company (NYSE: BDX). Known... 
Via Finterra
Topics Artificial Intelligence
News headline image
Pure-Play Pivot: Decoding Becton Dickinson’s (BDX) Q1 Results and the $17.5B Waters Combination
Today, February 9, 2026, marks a watershed moment for Becton, Dickinson and Company (NYSE: BDX). The medical technology giant, commonly known as BD, has officially closed its transformative $17.5... 
Via Finterra
Topics Artificial Intelligence Economy Product Recall
News headline image
3 Healthcare Stocks Paying the Highest Dividends of 2026 ↗
Which of the highest-yielding healthcare stocks are value traps or golden opportunities? 
Via The Motley Fool
News headline image
Embecta (EMBC) Q1 2026 Earnings Call Transcript ↗
Embecta (EMBC) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Precision Medicine and the Tubeless Revolution: An In-Depth Look at Insulet Corporation (PODD)
Today’s Date: January 9, 2026 Introduction In the rapidly evolving landscape of medical technology, few companies have managed to fundamentally reshape a multi-decade standard of care as successfully... 
Via PredictStreet
Topics Economy Product Recall World Trade
News headline image
Embecta (EMBC) Q4 2025 Earnings Call Transcript ↗
Embecta (EMBC) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Embecta Corp (NASDAQ:EMBC) Reports Q4 Earnings Miss, Provides FY 2026 Outlook ↗
Embecta (EMBC) reported Q4 earnings, missing EPS and revenue estimates. The stock rose as investors focused on the company's positive fiscal 2026 guidance and dividend. 
Via Chartmill
Topics Earnings
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Embecta Corp (NASDAQ:EMBC) Surpasses Q3 Earnings Estimates, Shares Jump 10.5% in Pre-Market Trading ↗
Embecta Corp (EMBC) beats Q3 2025 earnings estimates with $295.5M revenue and $1.12 EPS, sparking a 10.5% pre-market stock surge. Strong performance may lift full-year forecasts. 
Via Chartmill
News headline image
Earnings Scheduled For August 8, 2025 ↗
 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.